Silk Road Medical Inc expected to post a loss of 43 cents a share - Earnings Preview

Silk Road Medical

05/11/2022 01:33

* Silk Road Medical Inc  SILK.OQ   SILK.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
8. 
    * The Sunnyvale California-based  company is expected to
report  a
36.2% increase in revenue to $33.635 million from $24.7 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Silk Road Medical
Inc is
for a loss of 43 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Silk Road
Medical
Inc is $45​, above​ its last closing price of $42.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.47       -0.46      -0.43     Beat    6.6
 Mar. 31 2022  -0.40       -0.37      -0.48     Missed  -29.1
 Dec. 31 2021  -0.37       -0.36      -0.42     Missed  -17.6​
 Sep. 30 2021  -0.30       -0.30      -0.40     Missed  -32.9
 ​​Jun.        -0.36       -0.37      -0.31     Beat    15.1
 30 2021                                                
 Mar. 31 2021  -0.42       -0.39      -0.31     Beat    20.7​
 Dec. 31 2020  -0.27       -0.28      -0.49     Missed  -75.3
 Sep. 30 2020  -0.29       -0.29      -0.31     Missed  -8.7
 This summary was machine generated November 5 at 01:33 GMT.  All
figures in US dollars  unless otherwise stated